{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:24:04Z","timestamp":1787268244709,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02352-5","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:35:09Z","timestamp":1781166909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the diagnostic performance of alanine aminotransferase and ultrasonography for discrimination of liver biopsy proven metabolic associated steatotic liver disease: a ROC curve analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Mahider Shimelis","family":"Feyisa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermias Bekele","family":"Enyew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel Birhanu","family":"Arage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayenew","family":"Berhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birhantinsae","family":"Kefyalew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teklehaimanot","family":"Kiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruktawit","family":"Eshetu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getaneh","family":"Mola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"issue":"3","key":"2352_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"Tacke F, Horn P, Wai-Sun Wong V, Ratziu V, Bugianesi E, Francque S, et al. EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542.","journal-title":"J Hepatol"},{"issue":"1","key":"2352_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat reviews Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat reviews Gastroenterol Hepatol"},{"issue":"1","key":"2352_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4314\/ejhs.v28i1.4","volume":"28","author":"B Zawdie","year":"2018","unstructured":"Zawdie B, Tadesse S, Wolide AD, Nigatu TA, Bobasa EM. Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia. Ethiop J health Sci. 2018;28(1):19\u201330.","journal-title":"Ethiop J health Sci"},{"issue":"1","key":"2352_CR4","doi-asserted-by":"publisher","first-page":"5555842","DOI":"10.1155\/jdr\/5555842","volume":"2025","author":"EA Berhe","year":"2025","unstructured":"Berhe EA, Sema RA, Tesfaye YM, Berhane AA, Dawit M, Gebrehiwot EM, et al. Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia. J Diabetes Res. 2025;2025(1):5555842.","journal-title":"J Diabetes Res"},{"issue":"2","key":"2352_CR5","doi-asserted-by":"publisher","first-page":"e71773","DOI":"10.1002\/hsr2.71773","volume":"9","author":"MS Feyisa","year":"2026","unstructured":"Feyisa MS, Ambachew S, Mebratie AF, Ali BE, Asefa RH, Asefa EC, et al. Nonalcoholic Fatty Liver Disease Status and Its Associated Factors Among Patients With Type 2 Diabetes Mellitus in Adama Hospital Medical College, South Eastern Ethiopia: A Cross-Sectional Study. Health Sci Rep. 2026;9(2):e71773.","journal-title":"Health Sci Rep"},{"key":"2352_CR6","doi-asserted-by":"crossref","unstructured":"Jin H, Liang Z, Hu X, Li X, Liu Z, Qiao Y et al. Comparative association of MAFLD\/MASLD and Subtypes with Cardiovascular Diseases Outcomes. Nutr Metabolism Cardiovasc Dis. 2025;35(6):104024.","DOI":"10.1016\/j.numecd.2025.104024"},{"key":"2352_CR7","first-page":"117955142614369","volume":"19","author":"MS Feyisa","year":"2026","unstructured":"Feyisa MS, Eshetu B, Arage RB, Erega BB, Berhan A, Kiros T, et al. Assessment of Dyslipidemia and its Associated Factors Among Non-Alcoholic Fatty Liver Disease Diagnosed Type 2 Diabetes Mellitus Patients in Adama Hospital Medical College: A Cross-Sectional Study. Clin Med Insights: Endocrinol Diabetes. 2026;19:11795514261436946.","journal-title":"Clin Med Insights: Endocrinol Diabetes"},{"key":"2352_CR8","doi-asserted-by":"publisher","unstructured":"Xi Y, Liang Z, Jin H, Jiang Y, Tan R, Zhang Y et al. Association of total and regional fat-to-muscle ratio with the risk of metabolic dysfunction-associated fatty liver disease and other chronic liver diseases. Hep Intl. 2026:1\u201313. https:\/\/doi.org\/10.1007\/s12072-026-11064-w","DOI":"10.1007\/s12072-026-11064-w"},{"issue":"Suppl 1","key":"2352_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000447277","volume":"34","author":"NM De Alwis","year":"2016","unstructured":"De Alwis NM, Anstee QM, Day CP. How to diagnose nonalcoholic fatty liver disease. Dig Dis. 2016;34(Suppl 1):19\u201326.","journal-title":"Dig Dis"},{"issue":"7","key":"2352_CR10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.cgh.2014.11.027","volume":"13","author":"SC Lin","year":"2015","unstructured":"Lin SC, Heba E, Wolfson T, Ang B, Gamst A, Han A, et al. Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique. Clin Gastroenterol Hepatol. 2015;13(7):1337\u201345. e6.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2352_CR11","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.radi.2024.07.006","volume":"30","author":"B Ezenwuba","year":"2024","unstructured":"Ezenwuba B, Hynes C. Ultrasound screening of paediatric non-alcoholic fatty liver disease (NAFLD): A critical literature review. Radiography. 2024;30(5):1317\u201325.","journal-title":"Radiography"},{"issue":"4","key":"2352_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10396-020-01058-y","volume":"47","author":"T Tada","year":"2020","unstructured":"Tada T, Nishimura T, Yoshida M, Iijima H. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography. J Med Ultrason. 2020;47(4):511\u201320.","journal-title":"J Med Ultrason"},{"issue":"1","key":"2352_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12876-020-1165-z","volume":"20","author":"X Ma","year":"2020","unstructured":"Ma X, Liu S, Zhang J, Dong M, Wang Y, Wang M, et al. Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. BMC Gastroenterol. 2020;20(1):10.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"2352_CR14","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00125-016-3944-1","volume":"59","author":"H Yki-J\u00e4rvinen","year":"2016","unstructured":"Yki-J\u00e4rvinen H. Diagnosis of non-alcoholic fatty liver disease (NAFLD). Diabetologia. 2016;59(6):1104\u201311.","journal-title":"Diabetologia"},{"key":"2352_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejim.2024.01.013","volume":"122","author":"M Zoncape","year":"2024","unstructured":"Zoncape M, Liguori A, Tsochatzis EA. Non-invasive testing and risk-stratification in patients with MASLD. Eur J Intern Med. 2024;122:11\u20139.","journal-title":"Eur J Intern Med"},{"issue":"5","key":"2352_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1586\/17474124.2015.1007955","volume":"9","author":"S Ballestri","year":"2015","unstructured":"Ballestri S, Romagnoli D, Nascimbeni F, Francica G, Lonardo A. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. Expert Rev Gastroenterol Hepatol. 2015;9(5):603\u201327.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"2352_CR17","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"Suppl 4","key":"2352_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jgh.12271","volume":"28","author":"E Hashimoto","year":"2013","unstructured":"Hashimoto E, Taniai M, Tokushige K. Characteristics and diagnosis of NAFLD\/NASH. J Gastroenterol Hepatol. 2013;28(Suppl 4):64\u201370.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"2352_CR19","doi-asserted-by":"publisher","first-page":"e16127","DOI":"10.1111\/liv.16127","volume":"45","author":"J Cathcart","year":"2025","unstructured":"Cathcart J, Barrett R, Bowness JS, Mukhopadhya A, Lynch R, Dillon JF. Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review. Liver international: official J Int Association Study Liver. 2025;45(4):e16127.","journal-title":"Liver international: official J Int Association Study Liver"},{"issue":"3","key":"2352_CR20","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","volume":"13","author":"F Abdelhameed","year":"2024","unstructured":"Abdelhameed F, Kite C, Lagojda L, Dallaway A, Chatha KK, Chaggar SS, et al. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD. Curr Obes Rep. 2024;13(3):510\u201331.","journal-title":"Curr Obes Rep"},{"issue":"6","key":"2352_CR21","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00431-019-03362-3","volume":"178","author":"LG Draijer","year":"2019","unstructured":"Draijer LG, Feddouli S, Bohte AE, vd Baan Slootweg O, Pels Rijcken TH, Benninga MA, et al. Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease. Eur J Pediatrics. 2019;178(6):863\u201370.","journal-title":"Eur J Pediatrics"},{"key":"2352_CR22","first-page":"e083182","volume":"390","author":"R Strandberg","year":"2025","unstructured":"Strandberg R, \u00c5berg F, Asteljoki JV, Luukkonen PK, Salomaa V, Jula A, et al. Use of new CORE risk score to predict 10 year risk of liver cirrhosis in general population: population based cohort study. BMJ (Clinical Res ed). 2025;390:e083182.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"1","key":"2352_CR23","first-page":"16","volume":"6","author":"H Turkon","year":"2015","unstructured":"Turkon H, Colak A, Toprak B, YILDIZ C, Hasturk A, YILDIZ O, et al. Diagnostic performances of serum liver enzymes and cytokines in non-alcoholic fatty liver disease. J Clin Experimental Investigations. 2015;6(1):16\u201320.","journal-title":"J Clin Experimental Investigations"},{"issue":"3","key":"2352_CR24","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology (Baltimore MD). 2011;54(3):1082\u201390.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"1","key":"2352_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12874-026-02768-6","volume":"26","author":"B Emir","year":"2026","unstructured":"Emir B, Can FE, Kaymaz E, Ozel Z, Efgan MG, Tekindal MA, et al. Sample size and power analysis for ROC AUC differences in diagnostic tests: a methodological evaluation of the Obuchowski-McClish and Hanley-McNeil methods. BMC Med Res Methodol. 2026;26(1):43.","journal-title":"BMC Med Res Methodol"},{"key":"2352_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jclinepi.2019.02.004","volume":"110","author":"E Christodoulou","year":"2019","unstructured":"Christodoulou E, Ma J, Collins GS, Steyerberg EW, Verbakel JY, Van Calster B. A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. J Clin Epidemiol. 2019;110:12\u201322.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2352_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/diagnostics10060431","volume":"10","author":"C Ibacahe","year":"2020","unstructured":"Ibacahe C, Correa-Burrows P, Burrows R, Barrera G, Kim E, Hirsch S, et al. Accuracy of a Semi-Quantitative Ultrasound Method to Determine Liver Fat Infiltration in Early Adulthood. Diagnostics. 2020;10(6):431.","journal-title":"Diagnostics"},{"key":"2352_CR28","doi-asserted-by":"publisher","first-page":"1302322","DOI":"10.3389\/fendo.2023.1302322","volume":"14","author":"J Qiu","year":"2023","unstructured":"Qiu J, Kuang M, He S, Yu C, Wang C, Huang X, et al. Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population. Front Endocrinol. 2023;14:1302322.","journal-title":"Front Endocrinol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02352-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02352-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02352-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T22:33:05Z","timestamp":1787265185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02352-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2352"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02352-5","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with Declaration of Helsinki and after obtaining ethical clearance from the internal ethical review committee of Debre Tabor University, College of Health Science, Medical Laboratory Sciences Education and Service Directorate (IRB) (Reference Number: 179\/2024). Participants who were willing to participate in the study provided a written informed consent and only when a participant was willing and ready to take part in the research did the data collection process start. Furthermore, relevant guidelines and regulations were followed in all process.","order":1,"name":"Ethics","label":"Ethical approval and consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest for this work.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"242"}}